JMKX003142 tablets

DRUG5 trials

Sponsors

Jemincare

Conditions

ADPKD (Autosomal Dominant Polycystic Kidney Disease)Edema LegEdema SecondaryNephrogenic EdemaRenal Edema

Phase 1

Mass Balance and Absolute Bioavailability Study of JMKX003142 In Healthy Volunteers

Not yet recruitingNCT07463053

JemincareADPKD (Autosomal Dominant Polycystic Kidney Disease)

Start: 2026-03-18End: 2026-06-11Target: 8Updated: 2026-03-10

A Study to Investigate the Effects of JMKX003142 on QTc Interval in Healthy Adults

Not yet recruitingNCT07470177

JemincareADPKD (Autosomal Dominant Polycystic Kidney Disease)

Start: 2026-03-27End: 2026-06-23Target: 24Updated: 2026-03-13

Drug-Drug Interactions of JMKX003142 in Healthy Participants

Not yet recruitingNCT07565441

JemincareADPKD (Autosomal Dominant Polycystic Kidney Disease)

Start: 2026-05-11End: 2027-02-28Target: 112Updated: 2026-05-04

Phase 2

A Dose-finding Study of JMKX003142 in Treatment of Renal Edema

CompletedNCT06670534

JemincareEdema Leg, Edema Secondary

Start: 2025-10-17End: 2026-05-12Updated: 2026-08-10

Phase 3

A Study of JMKX003142 Tablet to Treat Renal Edema

Not yet recruitingNCT07841093

JemincareNephrogenic Edema, Renal Edema

Start: 2027-02-28End: 2028-07-31Target: 240Updated: 2026-09-30